Metabolic complications of obesity

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 27, Issue 2, 2013, Pages 179-193

  Pedersen, Sue D ^a  

^a LMC Endocrinology Centre Calgary   (Canada)

Author keywords

gestational diabetes; metabolic syndrome X; obesity; polycystic ovary syndrome; prediabetic state; type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA;

ABDOMINAL OBESITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH CARE PERSONNEL; HUMAN; HYPERANDROGENISM; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; REVIEW; SCREENING;

BLOOD GLUCOSE; FEMALE; HUMANS; METABOLIC DISEASES; METABOLIC SYNDROME X; OBESITY; POLYCYSTIC OVARY SYNDROME; PREDIABETIC STATE;

EID: 84878594454     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2013.02.004     Document Type: Review

References (65)

1. S. Wild, G. Roglic, and A. Green Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053 (Pubitemid 38579764)
2. F.B. Hu, J.E. Manson, and M. Stampfer Diet, lifestyle, and the risk of type 2 diabetes mellitus in women New England Journal of Medicine 345 2001 790 797
3. K. Eeg-Olofsson, J. Cederholm, and P.M. Nilsson Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients Diabetologia 52 2009 65 73
4. R.M. Goldenberg, A.Y.Y. Cheng, and Z. Punthakee Use of glycated hemoglobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults Canadian Journal of Diabetes 2011 July 247 249
5. I. McCarthy Genomics, type 2 diabetes, and obesity New England Journal of Medicine 363 24 2010 2339 2350
6. A.A. Vaag, L.G. Grunnet, and G.P. Arora The thrifty phenotype hypothesis revisited Diabetologia 55 8 2012 2085 2088
7. P. Alonso-Magdalene, I. Quesada, and A. Nadal Endocrine disruptors in the etiology of type 2 diabetes mellitus Nature Reviews Endocrinology 7 6 2011 346 353
8. O.H. Franco, E.W. Steyerberg, and F.B. Hu Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease Archives of Internal Medicine 167 11 2007 1145 1151 (Pubitemid 46924742)
9. S.R. Seshasai, S. Kaptoge, A. Thompson Emerging Risk Factors Collaboration Diabetes mellitus, fasting glucose, and risk of cause-specific death New England Journal of Medicine 364 9 2011 829 841
10. American Diabetes Association Standards of medical care in diabetes-2010 Diabetes Care 33 Suppl. 1 2010 S11 S61
11. L. Rydén, E. Standl, and M. Bartnik Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) European Heart Journal 28 2007 88 136 (Pubitemid 46137814)
12. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada Canadian Journal of Diabetes 32 Suppl. 1 2008 S1 S201
13. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 9131 1998 837 853
14. R.R. Holman, S.K. Paul, and M.A. Bethel Ten-year follow-up of intensive glucose control in type 2 diabetes New England Journal of Medicine 359 15 2008 1577 1589
15. L.F. Meneghini, D. Orozco-Beltran, and K. Khunti Weight beneficial treatments for type 2 diabetes Journal of Clinical Endocrinology and Metabolism 96 11 2011 3337 3353
16. C. Schmid, P. Krayenbühl, and P. Wiesli Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes Diabetologia 52 2009 2668 2669
17. L.N. Pani, D.M. Nathan, and R.W. Grant Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7% Diabetes Care 31 2008 386 390
18. K. Hermansen, and L.S. Mortensen Body weight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus Drug Safety 30 2007 1127 1142 (Pubitemid 350172854)
19. M. Lind Incretin therapy and its effect on body weight in patients with diabetes Primary Care Diabetes 6 3 2012 187 191
20. S. Cornell Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes Journal of Clinical Pharmacy and Therapeutics 2012 10.1111/j.1365-2710.2012.01342.x
21. D.L. Williams Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis Endocrinology 150 2009 2997 3001
22. National Diabetes Statistics Fast facts on diabetes 2011 National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health http://diabetes.niddk.nih.gov/dm/pubs/statistics/ [accessed online 08.09.12]
23. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. [accessed online 10.11.12].
24. American Diabetes, Association Diagnosis and classification of diabetes mellitus Diabetes Care 28 Suppl. 1 2005 S37 S42
25. D.M. Nathan, M.B. Davidson, and R.A. DeFronzo American Diabetes Association Impaired fasting glucose and impaired glucose tolerance: implications for care Diabetes Care 30 3 2007 753 759 (Pubitemid 46354366)
26. M. Coutinho, H.C. Gerstein, and Y. Wang The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 1999 233 240 (Pubitemid 29056916)
27. M. Tominaga, H. Eguchi, and H. Manaka Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose Diabetes Care 22 1999 920 924 (Pubitemid 29241045)
28. J. Tuomilehto, J. Lindstrom, and J.G. Eriksson Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance New England Journal of Medicine 344 2001 1343 1350 (Pubitemid 32378388)
29. J. Lindström, P. Ilanne-Parikka, and M. Peltonen Finnish Diabetes Prevention Study Group Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow up of the Finnish Diabetes Prevention Study Lancet 368 9548 2006 1673 1679 (Pubitemid 46048554)
30. W.C. Knowler, E. Barrett-Connor, and S.E. Fowler Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin New England Journal of Medicine 246 2002 393 403 (Pubitemid 34437694)
31. U. Yoon, L.L. Kwok, and A. Magkidis Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials Metabolism 2012 Sept [Epub ahead of print]
32. B. Lindahl, T.K. NilssoÅNn, and K. Borch-Johnsen A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-term impact but long-term adherence problems Scandinavian Journal of Public Health 37 4 2009 434 442
33. S.R. Salpeter, N.S. Buckley, and J.A. Kahn Meta-analysis: metformin treatment in persons at risk for diabetes mellitus American Journal of Medicine 121 2 2008 149 157.e2
34. J.S. Torgerson, J. Hauptman, and M.N. Boldrin XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients Diabetes Care 27 1 2004 155 161 (Pubitemid 38196725)
35. S.B. Heymsfield, K.R. Segal, and J. Hauptman Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults Archives of Internal Medicine 160 9 2000 1321 1326 (Pubitemid 30252779)
36. B.E. Metzger, and D.R. Coustan Summary and recommendations of the Fourth International Workshop-Conference on Gestation Diabetes Melitus Diabetes Care 21 Suppl. 2 1998 B161 B167
37. B.E. Metzger, S.G. Gabbe, and B. Persson International Association of Diabetes and Pregnancy Study Groups Consensus Panel International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy Diabetes Care 33 3 2010 676 692
38. E.A. Ryan Diagnosing gestational diabetes Diabetologia 54 3 2011 480 486
39. O. Langer, J.G. Umans, and M. Miodovnik Perspectives on the proposed gestational diabetes mellitus diagnostic criteria Obstetrics and Gynecology 2012 Oct 19 [Epub ahead of print]
40. J. Singh, C.C. Huang, and R.W. Driggers The impact of pre-pregnancy body mass index on the risk of gestational diabetes Journal of Maternal, Fetal, and Neonatal Medicine 25 1 2012 5 10
41. M.M. Hedderson, M.A. Williams, and V.L. Holt Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus American Journal of Obstetrics and Gynecology 198 4 2008 409.e1
42. Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight gain during pregnancy: reexamining the guidelines. Rasmussen KM, Yaktine AL, editors. National Academies Press (US), The National Academies Collection. Available at: http://www.nap.edu/catalog/12584.html.
43. T.A. Buchanan, and A.H. Xiang Gestational diabetes mellitus Journal of Clinical Investigation 115 3 2005 485
44. S.M. Grundy, J.I. Cleeman, and S.R. Daniels American Heart Association, National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 17 2005 2735
45. International Diabetes Federation The IDF consensus worldwide definition of the metabolic syndrome 2006 http://www.idf.org/webdata/docs/MetS-def- update2006.pdf [Accessed on 30.10.12]
46. Y.W. Park, S. Zhu, and L. Palaniappan The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Archives of Internal Medicine 163 4 2003 427 436 (Pubitemid 36241019)
47. L. Palaniappan, M.R. Carnethon, and Y. Wang Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study Diabetes Care 27 3 2004 788 793 (Pubitemid 38280551)
48. J.L. Rosenzweig, E. Ferrannini, and S.M. Grundy Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline Journal of Clinical Endocrinology and Metabolism 93 10 2008 3671 3689
49. R. Azziz, K.S. Woods, and R. Reyna The prevalence and features of the polycystic ovary syndrome in an unselected population Journal of Clinical Endocrinology and Metabolism 89 6 2004 2745 2749 (Pubitemid 38766360)
50. G. Kosova, and M. Urbanek Genetics of the polycystic ovary syndrome Molecular and Cellular Endocrinology 2012 10.1016/j.mce.2012.10.009
51. J.E. Nestler, D.J. Jakubowicz, and A.F. de Vargas Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system Journal of Clinical Endocrinology and Metabolism 83 6 1998 2001 2005 (Pubitemid 28496328)
52. J.E. Nestler, L.P. Powers, and D.W. Matt A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 72 1 1991 83 89 (Pubitemid 21921660)
53. A.J. Jakimiuk, S.R. Weitsman, and A. Navab Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries Journal of Clinical Endocrinology and Metabolism 86 3 2001 1318 1323 (Pubitemid 32323023)
54. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertility and Sterility 81 2004 19 25
55. R. Azziz, L.A. Sanchez, and E.S. Knochenhauer Androgen excess in women: experience with over 1000 consecutive patients Journal of Clinical Endocrinology and Metabolism 89 2 2004 453 462 (Pubitemid 38269843)
56. R.S. Legro, A.R. Kunselman, and W.C. Dodson Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women Journal of Clinical Endocrinology and Metabolism 84 1999 165 169 (Pubitemid 29036695)
57. H.S. Randeva, B.K. Tan, and M.O. Weikert Cardiometabolic aspects of the polycystic ovary syndrome Endocrinology Reviews 33 5 2012 812 841
58. S. Tan, L.P. Bechmann, and S. Benson Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 95 2010 343 348
59. Y. Gutierrez-Grobe, G. Ponciano-Rodríguez, and M.H. Ramos Prevalence of non alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens Annals of Hepatology 9 2010 402 409
60. M.M. Brzozowska, G. Ostapowicz, and M.D. Weltman An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome Journal of Gastroenterology and Hepatology 24 2009 243 247
61. T.L. Setji, N.D. Holland, and L.L. Sanders Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 91 2006 1741 1747
62. A.N. Vgontzas, R.S. Legro, and E.O. Bixler Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance Journal of Clinical Endocrinology and Metabolism 86 2001 517 520 (Pubitemid 32207453)
63. E. Tasali, F. Chapotot, and R. Leproult Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 96 2011 365 374
64. M.L. Misso, H.J. Teede, and R. Hart Status of clomiphene citrate and metformin for infertility in PCOS Trends in Endocrinology and Metabolism 23 10 2012 533 543
65. K.A. Martin, R.J. Chang, and D.A. Ehrmann Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline Journal of Clinical Endocrinology and Metabolism 93 4 2008 1105 1120 (Pubitemid 351519694)